,index,PatientGuid,DiagnosisGuid,ICD9Code,DiagnosisDescription,StartYear_y,StopYear,Acute
0,152818,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,89B49E18-CAEC-4C37-BDD0-4601DB10945D,288.60,Leukocytosis unspecified,2011.0,,0
0,152826,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,CF5BC129-966C-477D-AD36-6D7C20F14F0F,427.2,Paroxysmal tachycardia unspecified,2011.0,,0
0,152834,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,6575B223-E147-4AB3-A64E-8DCF34453B23,272.1,Pure hyperglyceridemia,2011.0,,0
0,152842,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,E5B6655C-CE05-4F4B-9EB6-8E1D5DFC0C65,786.09,Other dyspnea and respiratory abnormality,2011.0,2011.0,0
0,152850,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,A6870A1E-A741-413E-A80E-AF740E163044,783.21,Loss of weight,2011.0,,0
0,152858,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,4B5DC9A5-B926-43D1-900B-C361C59DF391,995.2,Unspec adverse effect of drug due to proper administration,2011.0,,0
0,152866,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,0A390979-1969-4A14-9BCC-D2EA2A1DFB9C,110.5,Dermatophytosis of the body,2011.0,,0
0,152874,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,C98B296F-4C90-4A53-A37D-EA320F2D12F0,251.2,Hypoglycemia unspecified,2011.0,,0
0,152882,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,61F5391E-5B7B-4B64-9BC3-ED810DB41ACB,V01.9,Contact with or exposure to unspecified communicable disease,2010.0,,0
0,152890,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,2D04DE43-ACB1-4C69-829B-8968793DDC26,530.81,Esophageal reflux,2011.0,,0
0,152906,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,3C95AC5F-E57B-44ED-8CDC-9C1D446C68D0,493.00,Extrinsic asthma without mention of status asthmaticus,2011.0,,0
0,152914,FDA60E49-ADF3-4F22-AFE9-BBD031629E0D,7CC35157-EE90-49A7-9BAB-E6DAFD85D7DE,995.3,Allergy unspecified not elsewhere classified,2011.0,2011.0,0
